希瑪眼科(03309.HK)有興趣在整個大灣區布局
希瑪眼科(03309.HK)主席兼行政總裁林順潮在股東會後表示,公司內地業務發展勢頭良好,樂見深圳眼科醫院的盈利保持強勢,北京的眼科醫院則因為仍處於建設期,因此在2018年度錄得虧損,但他預期在今年上半年虧損將會大幅度收窄,料會在明年起開始錄得盈利。
他又透露,收購上海璐視德醫療後,目前正進行前期工作,相信會在7至8月正式接手,由於不是由零開始建設,因此有信心會在一年內轉虧為盈。另外,昆明的醫院將在本周六正式開幕。惠州方面,今年第三至第四季亦將有醫院開業。
他續指,集團有興趣在整個大灣區布局,主要是視乎該地區人口及需求。至於香港業務仍會繼續努力發展,醫生團隊人數及衛星診所仍在擴展中,因此營業額及盈利仍有上升空間。
林順潮表示,雖然中美貿易磨擦會對中國消費帶來影響,但樂見內地政府積極推動大健康發展,加上在經濟欠佳時,收購醫院的成本亦會相對便宜。他提到目前公司的現金流狀況健康,若將來遇上好的項目,亦不排除會有進一步融資需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.